EGFR and non-small cell lung carcinoma: Contrary to the classic theory of a change to systemic therapy with all types of treatment failure, a treatment strategy incorporating aggressive LAT while maintaining EGFR‐TKI therapy has been attempted to eradicate the locally‐remaining or PD in metastatic EGFR‐mutated NSCLC.12, 13